Home
Concord Biotech

Concord Biotech Market Share Analysis for November 2025

Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation based biopharmaceutical active pharmaceutical ingredients sold worldwide. Concord was founded in 2000 by Sudhir Vaid.

Health > Biotechnology and Pharmaceuticals

Domainconcordbiotech.com

Year Founded2000

Employees501 - 1000

Annual Revenue> $1B

Concord Biotech

Concord Biotech (including company regionals)

concordbiotech.com

See more website traffic and engagement information

Concord Biotech Revenue up to November 2025 is > 1B

revenue generated by Concord Biotech top domains

Concord Biotech top domains revenue over 3 years

Revenue for Concord Biotech top domains

concordbiotech.com> 1B

See more with Sales Intelligence

Total visits to Concord Biotech's top domains

Understand Concord Biotech market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

concordbiotech.com3.8K

See more with Sales Intelligence

Avg. visit duration in Concord Biotech's top domains

Analyze Concord Biotech engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

concordbiotech.com00:02:40

See more with Sales Intelligence

Avg. pageviews on Concord Biotech's top domains

See how Concord Biotech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

concordbiotech.com3.82

See more with Sales Intelligence

Concord Biotech top competitors by domain

Top similar sites in November 2025, ranked by their affinity

swisspharma.inCompany NameSwiss PharmaEmployees201 - 500HQIndia, AhmedabadAnnual revenue$5M - $10MTotal visits860Health > Biotechnology and Pharmaceuticals

Top technologies used by Concord Biotech

These are the website technologies, by industry, used by Concord Biotech top domains

Payment & Currencies (8)

Cart Functionality

Widget (7)

Twemoji

Advertising (3)

DoubleClick

eCommerce (3)

Swap

More Technologies

8

See all

News & Signals from Concord Biotech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsConcord Biotech Limited had issues with marketing approval for its teriflunomide 7 mg and 14 mg tablets on Apr 8th '25.Concord Biotech on Tuesday, April 8, announced that it received marketing approval for its teriflunomide 7 mg and 14 mg tablets from the United States Food and Drug Administration (USFDA).

NewsConcord Biotech Limited invested into Palvella Therapeutics, Inc $1M on Dec 12th '24.Concord Biotech Ltd on Thursday said it has invested USD 10 lakh (nearly Rs 85 crore) in US-based Palvella Therapeutics, Inc with an aim to establish a partnership to manufacture and commercialise 'Qtorin', a drug used to treat serious and rare genetic skin diseases.

NewsConcord Biotech Limited went public on Aug 18th '23.Concord Biotech's IPO was backed by the Jhunjhunwala family when the shares debuted in August 2023.